Chemed Financials - Benzinga

Chemed Corp

CHENYSE

Trade with Public

Trade with Public

$519.76

4.590.89%

Dern. MÀJ: Sep 2, 11:08 AM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

Chemed Financials

Chemed (CHE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Chemed Q2 Adj. EPS $6.06 Beats $5.60 Estimate, Sales $673.251M Beat $665.037M Estimate

Chemed (NYSE:CHE) reported quarterly earnings of $6.06 per share which beat the analyst consensus estimate of $5.60 by 8.21 percent. This is a 41.92 percent increase over earnings of $4.27 per share from the same period

Benzinga Newsdesk

PRO
Chemed Raises FY2026 Adj EPS Guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 Est

Chemed (NYSE:CHE) raises FY2026 Adj EPS guidance from $24.00-$24.75 to $25.00-$25.75 vs $24.34 analyst estimate..

Benzinga Newsdesk

PRO
Chemed Raises FY2026 Adj EPS Guidance from $23.25-$24.25 to $24.00-$24.75 vs $23.88 Est

Chemed (NYSE:CHE) raises FY2026 Adj EPS guidance from $23.25-$24.25 to $24.00-$24.75 vs $23.88 analyst estimate..

Benzinga Newsdesk

PRO
Chemed Q1 Adj. EPS $5.65 Beats $5.30 Estimate, Sales $657.513M Beat $649.819M Estimate

Chemed (NYSE:CHE) reported quarterly earnings of $5.65 per share which beat the analyst consensus estimate of $5.30 by 6.6 percent. This is a 0.36 percent increase over earnings of $5.63 per share from the same period

Benzinga Newsdesk

Earnings Scheduled For April 23, 2026

Benzinga Insights

PRO
Chemed Sees FY2026 Adj EPS $23.25-$24.25 vs $25.41 Est

Chemed (NYSE:CHE) is looking for FY2026 Adj EPS of $23.25-$24.25 vs $25.41 analyst estimate..

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved